Colby S Shemesh
5PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 06, 2024
PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers.Rebecca Kristeleit, Alexandra Leary, Ana Oaknin
|Aug 31, 2023
Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma).Alexandra Drakaki, Thomas Powles, Aristotelis Bamias
|May 22, 2023
Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework.Colby S Shemesh, Phyllis Chan, Mathilde Marchand
|Oct 02, 2021
Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations.Vincent Lemaire, Colby S Shemesh, Anand Rotte
|Nov 26, 2020
Pan-cancer population pharmacokinetics and exposure-safety and -efficacy analyses of atezolizumab in patients with high tumor mutational burden.Colby S Shemesh, Phyllis Chan, Fatema A Legrand
Pageof 1
Frequent Collaborators
1 joint publications
Vincent Lemaire
1 joint publications
Phyllis Chan
1 joint publications
Antonio Gonçalves
1 joint publications
Benjamin Wu
1 joint publications
Stephen P Hack
1 joint publications
Rene Bruno
1 joint publications
Alexandra Drakaki
1 joint publications
Thomas Powles
1 joint publications
Aristotelis Bamias
1 joint publications
Juan Martin-Liberal
